Last update 23 Jan 2025
Henlix, Inc.

Henlix, Inc.

Private Company|
2015|
United States
|
hengenix.com

Overview

Related

5
Drugs associated with Henlix, Inc.
Serplulimab
Target
PD-1
Mechanism
PD-1 inhibitors
Active Org.
PT Kalbio Global MedikaPT Kalbio Global Medika [+6]
Originator Org.
Henlix Biotech Co., Ltd. [+1]
Active Indication
Non-squamous non-small cell lung cancer [+23]
Inactive Indication
Advanced Cervical Carcinoma [+4]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
CN
First Approval Date22 Mar 2022
Pimurutamab(Shanghai Henlius Biotech, Inc.)
Target
EGFR
Mechanism
EGFR antagonists
Active Org.
Shanghai Henlius Biotech, Inc.Shanghai Henlius Biotech, Inc. [+1]
Originator Org.
Shanghai Henlius Biotech, Inc.Shanghai Henlius Biotech, Inc.
Active Indication
Cutaneous Squamous Cell Carcinoma [+11]
Inactive Indication
Advanced Hepatocellular Carcinoma [+5]
Drug Highest PhasePhase 3
First Approval Ctry. / Loc.-
First Approval Date-
HLX-44
Target
nectin-4
Mechanism
nectin-4 inhibitors
Active Org.
Shanghai Henlius Biotech, Inc.Shanghai Henlius Biotech, Inc.
Originator Org.
Shanghai Henlius Biotech, Inc.Shanghai Henlius Biotech, Inc.
Active Indication
Solid tumor
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
5
Clinical Trials associated with Henlix, Inc.
NCT04169178
/ Unknown statusPhase 1
A Phase 1 Dose Finding/Expansion Study of HLX55, A Monoclonal Antibody Targeting Tyrosine-Protein Kinase MET (C-MET) in Patients With Advanced Solide Tumors Refactory to Standard Therapy
NCT04133259
/ Unknown statusPhase 2
An Exploratory Study to Evaluate The Efficacy And Safety of HLX10, A Humanized Monoclonal Antibody Targeting Programmed Death-1 (PD-1) Protein In Chronic Hepatitis B Patients
NCT03494231
/ TerminatedPhase 1
An Open-label, Dose Escalation Phase 1 Study to Investigate HLX06, a Humanized Monoclonal Antibody Targeting Human Vascular Endothelial Growth Factor Receptor-2, in Patients With Advanced Solid Tumors Refractory to Standard Therapy
100 Clinical Results associated with Henlix, Inc.
Login to view more data
0 Patents (Medical) associated with Henlix, Inc.
Login to view more data
1
Literatures (Medical) associated with Henlix, Inc.
Biosimilars of Monoclonal Antibodies
Product Analysis of Biosimilar Antibodies
100 Deals associated with Henlix, Inc.
Login to view more data
100 Translational Medicine associated with Henlix, Inc.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 29 Jan 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
5
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free